Dublin, April 24, 2020 (GLOBE NEWSWIRE) -- The "Amniotic Membrane - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global Amniotic Membrane market accounted for $979.07 million in 2018 and is expected to reach $2650.28 million by 2027 growing at a CAGR of 11.7% during the forecast period. Rise in the geriatric population, increase in technological advancements and surge in awareness to reduce healthcare costs are the major factors propelling the market growth. However, factors such as dearth of skilled professionals are hampering the market growth.

Amniotic membrane is a combination of tissues and cells which helps in wound healing by being as a foundation for re-development of soft tissues. These are most widely used in eye surgery as a biological bandage to heal or replace damaged eye tissue.

Based on the end user, the hospitals segment is going to have a lucrative growth during the forecast period due to common visits by patients and its ability to cater to a varied range of surgical interventions. By geography, North America is going to have a lucrative growth during the forecast period owing to increasing the number of ophthalmic surgeries in the United States due to the geriatric population and presence of well-established healthcare infrastructure.

Some of the key players profiled in the Amniotic Membrane Market include Tissue-Tech Inc. (Amniox Medical Inc.), Skye Biologics Inc., MiMedx Group Inc., Katena Products, Inc. (IOP Ophthalmics), Integra Lifesciences Holdings Corporation (Derma Sciences Inc.), Human Regenerative Technologies, LLC, FzioMed Inc., Applied Biologics LLC, Amnio Technology, LLC and AlliquaBioMedical Inc.

What the report offers:

Key Topics Covered:

1 Executive Summary

2 Preface2.1 Abstract2.2 Stake Holders2.3 Research Scope2.4 Research Methodology2.5 Research Sources

3 Market Trend Analysis3.1 Introduction3.2 Drivers3.3 Restraints3.4 Opportunities3.5 Threats3.6 Product Analysis3.7 Application Analysis3.8 End User Analysis3.9 Emerging Markets3.10 Impact of Covid-19

4 Porters Five Force Analysis4.1 Bargaining power of suppliers4.2 Bargaining power of buyers4.3 Threat of substitutes4.4 Threat of new entrants4.5 Competitive rivalry

5 Global Amniotic Membrane Market, By Product5.1 Introduction5.2 Cryopreserved Amniotic Membrane5.3 Lyophilization Amniotic Membrane5.4 Dehydrated Amniotic Membrane

6 Global Amniotic Membrane Market, By Age Group6.1 Introduction6.2 Children6.3 Adults

7 Global Amniotic Membrane Market, By Application7.1 Introduction7.2 Surgical Wounds7.3 Stem Cell Biology7.4 Regenerative Medicine7.5 Prenatal Diagnosis7.6 Ophthalmology

8 Global Amniotic Membrane Market, By End User8.1 Introduction8.2 Specialized Clinics8.3 Hospitals8.4 Ambulatory Surgical Centers8.5 Academic Research Centers & Laboratory

9 Global Amniotic Membrane Market, By Geography9.1 Introduction9.2 North America9.2.1 US9.2.2 Canada9.2.3 Mexico9.3 Europe9.3.1 Germany9.3.2 UK9.3.3 Italy9.3.4 France9.3.5 Spain9.3.6 Rest of Europe9.4 Asia Pacific9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 New Zealand9.4.6 South Korea9.4.7 Rest of Asia Pacific9.5 South America9.5.1 Argentina9.5.2 Brazil9.5.3 Chile9.5.4 Rest of South America9.6 Middle East & Africa9.6.1 Saudi Arabia9.6.2 UAE9.6.3 Qatar9.6.4 South Africa9.6.5 Rest of Middle East & Africa

10 Key Developments10.1 Agreements, Partnerships, Collaborations and Joint Ventures10.2 Acquisitions & Mergers10.3 New Product Launch10.4 Expansions10.5 Other Key Strategies

11 Company Profiling11.1 Tissue-Tech Inc (Amniox Medical Inc)11.2 Skye Biologics Inc11.3 MiMedx Group Inc11.4 Katena Products Inc (IOP Ophthalmics)11.5 Integra Lifesciences Holdings Corporation (Derma Sciences Inc)11.6 Human Regenerative Technologies LLC11.7 FzioMed Inc11.8 Applied Biologics LLC11.9 Amnio Technology LLC11.10 Alliqua BioMedical Inc

For more information about this report visit https://www.researchandmarkets.com/r/ft58l6

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Story continues

Go here to see the original:
Outlook on the Worldwide Amniotic Membrane Industry to 2027 - Strategic Recommendations for New Entrants - Yahoo Finance